Literature DB >> 31807497

How will nanotechnology lead to better control of asthma?

Bumhee Yang1, Hayoung Choi2, Sang-Heon Kim3, Ho Joo Yoon3, Hyun Lee3.   

Abstract

Entities:  

Year:  2019        PMID： 31807497      PMCID： PMC6861771          DOI： 10.21037/atm.2019.09.129

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  22 in total

Review 1.  Toxic potential of materials at the nanolevel.

Authors:  Andre Nel; Tian Xia; Lutz Mädler; Ning Li
Journal:  Science       Date:  2006-02-03       Impact factor: 47.728

Review 2.  Advances in nanotechnology and asthma.

Authors:  Lingwei Wang; Mengjie Feng; Qiuwen Li; Chen Qiu; Rongchang Chen
Journal:  Ann Transl Med       Date:  2019-04

3.  Burden of systemic glucocorticoid-related complications in severe asthma.

Authors:  Patrick Lefebvre; Mei Sheng Duh; Marie-Hélène Lafeuille; Laurence Gozalo; Urvi Desai; Marie-Noëlle Robitaille; Frank Albers; Steve Yancey; Hector Ortega; Mark Forshag; Xiwu Lin; Anand A Dalal
Journal:  Curr Med Res Opin       Date:  2016-10-14       Impact factor: 2.580

Review 4.  Nanotechnology based therapeutics for lung disease.

Authors:  Mohammad Doroudian; Ronan MacLoughlin; Fergus Poynton; Adriele Prina-Mello; Seamas C Donnelly
Journal:  Thorax       Date:  2019-07-08       Impact factor: 9.139

Review 5.  Role of Biologics in Asthma.

Authors:  Mary Clare McGregor; James G Krings; Parameswaran Nair; Mario Castro
Journal:  Am J Respir Crit Care Med       Date:  2019-02-15       Impact factor: 21.405

6.  Nano-salbutamol dry powder inhalation: a new approach for treating broncho-constrictive conditions.

Authors:  Farhan Jalees Ahmad; Gaurav Mittal; Gaurav K Jain; Geena Malhotra; Roop K Khar; Aseem Bhatnagar
Journal:  Eur J Pharm Biopharm       Date:  2008-10-10       Impact factor: 5.571

7.  Chitosan Interferon-gamma Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses.

Authors:  Xiaoyuan Kong; Gary R Hellermann; Weidong Zhang; Prasanna Jena; Mukesh Kumar; Aruna Behera; Sumita Behera; Richard Lockey; Shyam S Mohapatra
Journal:  Allergy Asthma Clin Immunol       Date:  2008-09-15       Impact factor: 3.406

Review 8.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 9.  Challenges in development of nanoparticle-based therapeutics.

Authors:  Neil Desai
Journal:  AAPS J       Date:  2012-03-10       Impact factor: 4.009

10.  Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.

Authors:  David B Price; Frank Trudo; Jaco Voorham; Xiao Xu; Marjan Kerkhof; Joanna Ling Zhi Jie; Trung N Tran
Journal:  J Asthma Allergy       Date:  2018-08-29
View more
  1 in total

Review 1.  Packaging and Delivery of Asthma Therapeutics.

Authors:  Bryan J Mathis; Misa Kusumoto; Alexander Zaboronok; Yuji Hiramatsu
Journal:  Pharmaceutics       Date:  2021-12-31       Impact factor: 6.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.